Page last updated: 2024-08-21

diphenylamine and Pseudomyxoma Peritonei

diphenylamine has been researched along with Pseudomyxoma Peritonei in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartlett, DL; Choudry, HA; Dilly, AK; Guo, ZS; Lee, YJ; Song, X; Zeh, HJ	1

Other Studies

1 other study(ies) available for diphenylamine and Pseudomyxoma Peritonei

Article	Year
Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth. Translational research : the journal of laboratory and clinical medicine, 2015, Volume: 166, Issue:4 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Humans; MAP Kinase Signaling System; Mice, Nude; Mitogen-Activated Protein Kinases; Mucin-2; Neoplasms, Cystic, Mucinous, and Serous; NF-kappa B; Peritoneal Neoplasms; Promoter Regions, Genetic; Protein Kinase Inhibitors; Pseudomyxoma Peritonei; Sulfonamides; Survival Analysis; Transcription Factor AP-1; Xenograft Model Antitumor Assays	2015

Article

Year

Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth.

Translational research : the journal of laboratory and clinical medicine, 2015, Volume: 166, Issue:4

Topics: Animals; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Humans; MAP Kinase Signaling System; Mice, Nude; Mitogen-Activated Protein Kinases; Mucin-2; Neoplasms, Cystic, Mucinous, and Serous; NF-kappa B; Peritoneal Neoplasms; Promoter Regions, Genetic; Protein Kinase Inhibitors; Pseudomyxoma Peritonei; Sulfonamides; Survival Analysis; Transcription Factor AP-1; Xenograft Model Antitumor Assays

2015